408 results on '"Hoermann, Rudolf"'
Search Results
2. Population data evidence of interdependence of the limbs of hormonal feedback loops
3. Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
4. Continuous home terlipressin infusion increases handgrip strength and reduces ascites—A prospective randomized crossover study
5. Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study
6. Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT
7. Changes in white adipose tissue gene expression in a randomized control trial of dieting obese men with lowered serum testosterone alone or in combination with testosterone treatment
8. Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial.
9. Re Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status.
10. A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese men
11. Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension study
12. Comment on “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”
13. The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis
14. sj-docx-1-tae-10.1177_20420188231158163 – Supplemental material for The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis
15. Time for a reassessment of the treatment of hypothyroidism
16. Modeling Supportive and Disruptive Mechanisms of FT3 Homeostasis: Supplementary Information
17. Störungen des Kalzium- und Knochenstoffwechsels
18. Endokrinologische Anamnesebögen
19. Referenzbereiche endokrinologischer Laborparameter
20. Vorgehen bei ausgewählten Schilddrüsenerkrankungen
21. Diabetes mellitus
22. Störungen der Nebennierenfunktion
23. Störungen der Hypophysenfunktion
24. Primärer Hyperaldosteronismus
25. Phäochromozytom
26. Hypophysenhinterlappen
27. Gonadotrope Funktion
28. Somatotrope Funktion
29. Corticotrope Funktion
30. Schilddrüsenerkrankungen
31. Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial
32. Physiological linkage of thyroid and pituitary sensitivities
33. Effects of androgen deprivation therapy on telomere length
34. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment
35. Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial
36. Minimal HPT Axis Model: Supplementary Information
37. Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial
38. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients
39. Principles of Endocrine Regulation: Reconciling Tensions Between Robustness in Performance and Adaptation to Change
40. Störungen der sexuellen Differenzierung und der Sexualfunktion
41. Additional file 4 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
42. Additional file 1 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
43. Additional file 2 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
44. Additional file 3 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
45. Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy
46. Androgen deprivation causes selective deficits in the biomechanical leg muscle function of men during walking: a prospective case–control study
47. Effects of aromatase inhibitor therapy on visceral adipose tissue area and cardiometabolic health in postmenopausal women with early and locally advanced breast cancer.
48. Effect of estradiol on cognition in men undergoing androgen deprivation therapy: A randomized placebo‐controlled trial
49. Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial
50. Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.